209 related articles for article (PubMed ID: 29559236)
21. Novel low-grade renal spindle cell neoplasm with HEY1::NCOA2 fusion that is distinct from mesenchymal chondrosarcoma.
Miller TI; Mantilla JG; Wang W; Liu YJ; Tretiakova M
Genes Chromosomes Cancer; 2023 Mar; 62(3):171-175. PubMed ID: 36416671
[TBL] [Abstract][Full Text] [Related]
22. Clinicopathologic features of 300 rhabdomyosarcomas with emphasis upon differential expression of skeletal muscle specific markers in the various subtypes: A single institutional experience.
Rekhi B; Gupta C; Chinnaswamy G; Qureshi S; Vora T; Khanna N; Laskar S
Ann Diagn Pathol; 2018 Oct; 36():50-60. PubMed ID: 30098515
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of new monoclonal anti-MyoD1 and anti-myogenin antibodies for the diagnosis of rhabdomyosarcoma.
Cui S; Hano H; Harada T; Takai S; Masui F; Ushigome S
Pathol Int; 1999 Jan; 49(1):62-8. PubMed ID: 10227726
[TBL] [Abstract][Full Text] [Related]
24. Sclerosing rhabdomyosarcoma: report of a case arising in the head and neck of an adult and review of the literature.
Robinson JC; Richardson MS; Neville BW; Day TA; Chi AC
Head Neck Pathol; 2013 Jun; 7(2):193-202. PubMed ID: 22990679
[TBL] [Abstract][Full Text] [Related]
25. An immunohistochemical algorithm to facilitate diagnosis and subtyping of rhabdomyosarcoma: the Children's Oncology Group experience.
Morotti RA; Nicol KK; Parham DM; Teot LA; Moore J; Hayes J; Meyer W; Qualman SJ;
Am J Surg Pathol; 2006 Aug; 30(8):962-8. PubMed ID: 16861966
[TBL] [Abstract][Full Text] [Related]
26. PAX7 Expression in Rhabdomyosarcoma, Related Soft Tissue Tumors, and Small Round Blue Cell Neoplasms.
Charville GW; Varma S; Forgó E; Dumont SN; Zambrano E; Trent JC; Lazar AJ; van de Rijn M
Am J Surg Pathol; 2016 Oct; 40(10):1305-15. PubMed ID: 27526298
[TBL] [Abstract][Full Text] [Related]
27. NKX3.1 immunohistochemistry is highly specific for the diagnosis of mesenchymal chondrosarcomas: experience in the Australian population.
Ramanayake N; Vargas AC; Talbot J; Bonar F; Wong DD; Wong D; Mahar A; Karim R; Luk PP; Selinger C; Sioson L; Gill AJ; Maclean F
Pathology; 2021 Oct; 53(6):705-712. PubMed ID: 33640159
[TBL] [Abstract][Full Text] [Related]
28. Novel MEIS1-NCOA2 Gene Fusions Define a Distinct Primitive Spindle Cell Sarcoma of the Kidney.
Argani P; Reuter VE; Kapur P; Brown JE; Sung YS; Zhang L; Williamson R; Francis G; Sommerville S; Swanson D; Dickson BC; Antonescu CR
Am J Surg Pathol; 2018 Nov; 42(11):1562-1570. PubMed ID: 30179902
[TBL] [Abstract][Full Text] [Related]
29. [Sclerosing rhabdomyosarcoma: a clinicopathologic study of four cases with review of literature].
Zhu L; Wang J
Zhonghua Bing Li Xue Za Zhi; 2007 Sep; 36(9):587-91. PubMed ID: 18070445
[TBL] [Abstract][Full Text] [Related]
30. [Spindle cell/sclerosing rhabdomyosarcoma: a clinicopathological study of 20 cases].
Yang L; Zhang HJ; Yang SJ
Zhonghua Bing Li Xue Za Zhi; 2020 Apr; 49(4):336-342. PubMed ID: 32268670
[No Abstract] [Full Text] [Related]
31. Chromosome aberrations and HEY1-NCOA2 fusion gene in a mesenchymal chondrosarcoma.
Panagopoulos I; Gorunova L; Bjerkehagen B; Boye K; Heim S
Oncol Rep; 2014 Jul; 32(1):40-4. PubMed ID: 24839999
[TBL] [Abstract][Full Text] [Related]
32. Type II collagen as specific marker for mesenchymal chondrosarcomas compared to other small cell sarcomas of the skeleton.
Müller S; Söder S; Oliveira AM; Inwards CY; Aigner T
Mod Pathol; 2005 Aug; 18(8):1088-94. PubMed ID: 15731776
[TBL] [Abstract][Full Text] [Related]
33. Rhabdomyosarcoma: From Obscurity to Clarity in Diagnosis … But With Ongoing Challenges in Management: The Farber-Landing Lecture of 2020.
Parham DM; Giannikopoulos P
Pediatr Dev Pathol; 2021; 24(2):87-95. PubMed ID: 33439112
[TBL] [Abstract][Full Text] [Related]
34. Rhabdomyosarcoma: Updates on classification and the necessity of molecular testing beyond immunohistochemistry.
Dehner CA; Rudzinski ER; Davis JL
Hum Pathol; 2024 May; 147():72-81. PubMed ID: 38135061
[TBL] [Abstract][Full Text] [Related]
35. NKX3.1 immunoreactivity is not identified in mesenchymal chondrosarcoma: a 25-case cohort study.
Chen W; Hornick JL; Fletcher CDM
Histopathology; 2021 Jan; 78(2):334-337. PubMed ID: 32779239
[TBL] [Abstract][Full Text] [Related]
36. Spindle cell/sclerosing rhabdomyosarcoma: case series from a single institution emphasizing morphology, immunohistochemistry and follow-up.
Zhao Z; Yin Y; Zhang J; Qi J; Zhang D; Ma Y; Wang Y; Li S; Zhou J
Int J Clin Exp Pathol; 2015; 8(11):13814-20. PubMed ID: 26823695
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic utility of NCOA2 fluorescence in situ hybridization and Stat6 immunohistochemistry staining for soft tissue angiofibroma and morphologically similar fibrovascular tumors.
Sugita S; Aoyama T; Kondo K; Keira Y; Ogino J; Nakanishi K; Kaya M; Emori M; Tsukahara T; Nakajima H; Takagi M; Hasegawa T
Hum Pathol; 2014 Aug; 45(8):1588-96. PubMed ID: 24856853
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of New Monoclonal Anti-MyoD1 (MX049) for the Diagnosis of Rhabdomyosarcoma: Comparison with 5.8A, EP212, Anti-Desmin, Anti-Myogenin, and Fluorescence
He Y; Chen X; Yu X
Ann Clin Lab Sci; 2020 May; 50(3):412-416. PubMed ID: 32581037
[TBL] [Abstract][Full Text] [Related]
39. Pleomorphic rhabdomyosarcoma in adults: a clinicopathologic study of 38 cases with emphasis on morphologic variants and recent skeletal muscle-specific markers.
Furlong MA; Mentzel T; Fanburg-Smith JC
Mod Pathol; 2001 Jun; 14(6):595-603. PubMed ID: 11406662
[TBL] [Abstract][Full Text] [Related]
40. Intraparenchymal mesenchymal chondrosarcoma of the frontal lobe--a case report and molecular detection of specific gene fusions from archival FFPE sample.
Sajjad EA; Sikora K; Paciejewski T; Garbicz F; Paskal W; Szacht M; Grajkowska W; Włodarski PK
Clin Neuropathol; 2015; 34(5):288-93. PubMed ID: 25907264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
